Emerging STING therapy combined with current standard could treat aggressive AML
CANCER DIGEST – May 12, 2024 – A new combination therapy may offer new hope to patients with an aggressive form of common leukemia,...
Adding daratumumab to standard treatment for Multiple Myeloma increases progression-free survival
CANCER DIGEST – Feb. 2, 2024 – Adding the drug daratumumab (Darzalex®) to standard treatment substantially increased survival in patients...
New treatment approach significantly improves survival for most common form of adult leukemia
Cancer Digest – Dec. 23, 2023 – Personalized treatment of the most common form of adult leukemia resulted in significantly longer...
Combination drug regimen sets new standard for GVHD prevention
CANCER DIGEST – July 1, 2023 – More than half of stem cell transplant patients who received a new drug combination survived free of...
Childhood cancer survivors can reduce risk of dying with healthy lifestyle
CANCER DIGEST – May 2, 2023 – Survivors of childhood cancer are at increased risk of dying from common causes such as cancer, heart...
Clinical trial for new treatment of rare blood cancer begins
CANCER DIGEST – April 8, 2023 – Researchers have found that restricting access to iron in red blood cells can effectively manage a rare...
